NCT03611127

Brief Summary

Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are associated with severe dyspnea and exercise intolerance. Early pulmonary rehabilitation (EPR) may lead to improvements in dyspnea and exercise tolerance, as it does in stable COPD patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Apr 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2017

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

July 10, 2018

Completed
23 days until next milestone

First Posted

Study publicly available on registry

August 2, 2018

Completed
Last Updated

August 2, 2018

Status Verified

July 1, 2018

Enrollment Period

1.3 years

First QC Date

July 10, 2018

Last Update Submit

July 31, 2018

Conditions

Outcome Measures

Primary Outcomes (4)

  • change in different aspects of dyspnea (dyspnea 12 questionnaire: scale range 0-36, with high score indicating worse dyspnea, and COPD assessment test: scale range 0-40, high score indicating worse dyspnea).

    dyspnea questionnaires

    8 weeks

  • change in exercise performance (borg scale during incremental exercise measuring the perceived dyspnea: scale 0-10, higher score indicating worse performance

    cardiopulmonary exercise tests

    8 weeks

  • change in exercise performance (test duration: longer duration measured in seconds indicating better performance)

    cardiopulmonary exercise tests

    8 weeks

  • change in exercise performance (Peak oxygen consumption: Higher values indicating better performance)

    cardiopulmonary exercise tests

    8 weeks

Study Arms (2)

early pulmonary rehabilitation (EPR)

EXPERIMENTAL

early pulmonary rehabilitation started shortly after hospital discharge for COPD exacerbation.

Other: pulmonary rehabilitation

Usual care (UC)

NO INTERVENTION

No pulmonary rehabilitation for this group

Interventions

pulmonary rehabilitation standardized program

early pulmonary rehabilitation (EPR)

Eligibility Criteria

Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Hospitalized COPD patients with a diagnosis of AECOPD with no clinically significant arterial hypoxemia at rest or on exercise (resting percutaneous oxygen saturation (SpO2) \> 90% or a sustained decrease of \< 4% during exercise) were recruited. Diagnosis of COPD, AECOPD and spirometric assessment of airflow limitation severity was based on Global Initiative for Chronic Obstructive Lung Disease (GOLD)

You may not qualify if:

  • Patients with a prior diagnosis of other cardiorespiratory conditions (i.e., bronchial asthma, interstitial lung diseases, primary pulmonary hypertension, chronic congestive heart failure), as well as other conditions such as orthopedic, muscular and peripheral vascular diseases that could cause or contribute to breathlessness and exercise intolerance and/or could interfere with carrying out of exercise testing, were excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Pulmonary medicine

Study Record Dates

First Submitted

July 10, 2018

First Posted

August 2, 2018

Study Start

April 15, 2016

Primary Completion

August 20, 2017

Study Completion

August 20, 2017

Last Updated

August 2, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share